Trials / Completed
CompletedNCT01920308
A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the deliverability, clinical utility and effectiveness of the 5 mm diameter size offering of the LifeStent® Vascular Stent
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 5 mm Bard LifeStent Vascular Stent | The LifeStent® Vascular Stent is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240 mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0 - 6.5 mm. |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-04-01
- Completion
- 2015-07-01
- First posted
- 2013-08-09
- Last updated
- 2016-11-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01920308. Inclusion in this directory is not an endorsement.